Cumulative morbidity and prognostic staging of illness in the systematic treatment enhancement program for bipolar disorder (STEP-BD)

Australian and New Zealand Journal of Psychiatry

Volumn 46, Issue 11, 2012, Pages 1058-1067

  Magalhães, Pedro Vieira ^a,b   Dodd, Seetal ^b,c   Nierenberg, Andrew A ^d   Berk, Michael ^b,c,e,f  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c DEAKIN UNIVERSITY   (Australia)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^f FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Bipolar disorder; cumulative morbidity; longitudinal; prognosis; staging

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DEPRESSION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DSM-IV; FEMALE; HEALTH PROGRAM; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MANIA; MORBIDITY; MULTICENTER STUDY; OPEN STUDY; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

ADULT; BIPOLAR DISORDER; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DEPRESSION; DISEASE PROGRESSION; FEMALE; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84870778826     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867412460593     Document Type: Article

References (65)

1. Alonso J, Petukhova M, Vilagut G, et al. Days out of role due to common physical and mental conditions: results from the WHO World Mental Health surveys. Molecular Psychiatry. 2011 ; 16: 1234-1246
2. Andreazza AC, Kapczinski F, Kauer-Sant'Anna M, et al. 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. Journal of Psychiatry & Neuroscience. 2009 ; 34: 236-271
3. Babyak MA. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosomatic Medicine. 2004 ; 66: 411-421 (Pubitemid 38668414)
4. Berk M. Neuroprogression: pathways to progressive brain changes in bipolar disorder. International Journal of Neuropsychopharmacology. 2009 ; 12: 441-445
5. Berk M, Parker G. The elephant on the couch: side-effects of psychotherapy. Australian and New Zealand Journal of Psychiatry. 2009 ; 43: 787-794
6. Berk M, Conus P, Lucas N, et al. Setting the stage: from prodrome to treatment resistance in bipolar disorder. Bipolar Disorders. 2007a ; 9: 671-678 (Pubitemid 350042401)
7. Berk M, Hallam KT, McGorry PD. The potential utility of a staging model as a course specifier: A bipolar disorder perspective. Journal of Affective Disorders. 2007b ; 100: 279-281 (Pubitemid 46818451)
8. Berk M, Singh A, Kapczinski F. When illness does not get better: do we need a palliative psychiatry?. Acta Neuropsychiatrica. 2008 ; 20: 165-166 (Pubitemid 351724933)
9. Berk M, Malhi GS, Hallam K, et al. Early intervention in bipolar disorders: Clinical, biochemical and neuroimaging imperatives. Journal of Affective Disorders. 2009 ; 114: 1-13
10. Berk M, Conus P, Kapczinski F, et al. From neuroprogression to neuroprotection: implications for clinical care. Medical Journal of Australia. 2010a ; 193: S36 - S40
11. Berk M, Hallam K, Malhi GS, et al. Evidence and implications for early intervention in bipolar disorder. Journal of Mental Health. 2010b ; 19: 113-126
12. Berk M, Brnabic A, Dodd S, et al. Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention. Bipolar Disorders. 2011a ; 13: 87-98
13. Berk M, Kapczinski F, Andreazza AC, et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neuroscience & Biobehavioral Reviews. 2011b ; 35: 804-817
14. Berk M, Berk L, Udina M, et al. Palliative models of care for later stages of mental disorder: maximizing recovery, maintaining hope, and building morale. Australian and New Zealand Journal of Psychiatry. 2012 ; 46: 92-99
15. Bertelsen M, Jeppesen P, Petersen L, et al. Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness: the OPUS trial. Archives of General Psychiatry. 2008 ; 65: 762-771 (Pubitemid 351957702)
16. Biewenga P, van der Velden J, Mo BW, et al. Validation of existing prognostic models in patients with early-stage cervical cancer. Gynecologic Oncology. 2009 ; 115: 277-284
17. Elhai JD, Calhoun PS, Ford JD. Statistical procedures for analyzing mental health services data. Psychiatry Research. 2008 ; 160: 129-136
18. Endicott J, Nee J, Harrison W, Blumenthal R. Quality-of-Life Enjoyment and Satisfaction Questionnaire - a new measure. Psychopharmacology Bulletin. 1993 ; 29: 321-326 (Pubitemid 23311543)
19. Fava GA, Kellner R. Staging - a neglected dimension in psychiatric classification. Acta Psychiatrica Scandinavica. 1993 ; 87: 225-230 (Pubitemid 23107270)
20. Francey SM, Nelson B, Thompson A, et al. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention. Schizophrenia Research. 2010 ; 119: 1-10
21. Goldberg JF, Brooks JO, Kurita K, et al. Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD. Journal of Clinical Psychiatry. 2009 ; 70: 155-162
22. Grande I, Magalhaes PV, Kunz M, et al. Mediators of allostasis and systemic toxicity in bipolar disorder. Physiology & Behavior. 2012 ; 106: 46-50
23. Gueorguieva R, Krystal JH. Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Archives of General Psychiatry. 2004 ; 61: 310-317 (Pubitemid 38295833)
24. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statistics in Medicine. 1996 ; 15: 361-387 (Pubitemid 26072233)
25. Judd LL, Akiskal HS, Schettler PJ, et al. Psychosocial disability in the course of bipolar I and II disorders - A prospective, comparative, longitudinal study. Archives of General Psychiatry. 2005 ; 62: 1322-1330 (Pubitemid 41746610)
26. Judd LL, Schettler PJ, Akiskal HS, et al. Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse/recurrence. Archives of General Psychiatry. 2008 ; 65: 386-394 (Pubitemid 351519888)
27. Kapczinski F, Vieta E, Andreazza AC, et al. Allostatic load in bipolar disorder: Implications for pathophysiology and treatment. Neuroscience and Biobehavioral Reviews. 2008 ; 32: 675-692
28. Kapczinski F, Dias VV, Kauer-Sant'Anna M, et al. Clinical implications of a staging model for bipolar disorders. Expert Review of Neurotherapeutics. 2009 ; 9: 957-966
29. Kapczinski F, Dal-Pizzol F, Teixeira AL, et al. A systemic toxicity index developed to assess peripheral changes in mood episodes. Molecular Psychiatry. 2010 ; 15: 784-786
30. Kapczinski F, Dal-Pizzol F, Teixeira AL, et al. Peripheral biomarkers and illness activity in bipolar disorder. Journal of Psychiatric Research. 2011 ; 45: 156-161
31. Kauer-Sant'Anna M, Kapczinski F, Andreazza AC, et al. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. International Journal of Neuropsychopharmacology. 2009 ; 12: 447-458
32. Keller MB, Lavori PW, Friedman B, et al. The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies. Archives of General Psychiatry. 1987 ; 44: 540-548 (Pubitemid 17082095)
33. Kilbourne AM, Post EP, Nossek A, et al. Improving medical and psychiatric outcomes among individuals with bipolar disorder: A randomized controlled trial. Psychiatric Services. 2008 ; 59: 760-768
34. Kupfer DJ. The increasing medical burden in bipolar disorder. JAMA. 2005 ; 293: 2528-2530 (Pubitemid 40705735)
35. McEwen BS. Mood disorders and allostatic load. Biological Psychiatry. 2003 ; 54: 200-207 (Pubitemid 37267851)
36. McGorry PD. Issues for DSM-V: Clinical staging: A heuristic pathway to valid nosology and safer, more effective treatment in psychiatry. American Journal of Psychiatry. 2007 ; 164: 859-860 (Pubitemid 46972899)
37. McGorry PD, Purcell R, Hickie IB, et al. Clinical staging: a heuristic model for psychiatry and youth mental health. Medical Journal of Australia. 2007 ; 187: S40 - S42
38. McGorry PD, Hickie IB, Yung AR, et al. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Australian and New Zealand Journal of Psychiatry. 2006 ; 40: 616-622 (Pubitemid 43984963)
39. McGorry PD, Nelson B, Goldstone S, et al. Clinical staging: a heuristic and practical strategy for new research and better health and social outcomes for psychotic and related mood disorders. Canadian Journal of Psychiatry. 2010 ; 55: 486-497
40. MacNeil CA, Hallam K, Conus P, et al. Are we missing opportunities for early intervention in bipolar disorder?. Expert Review of Neurotherapy. 2012 ; 12: 5-7
41. Magalhaes PV, Dean OM, Bush AI, et al. Systemic illness moderates the impact of N-acetyl cysteine in bipolar disorder. Progress in Neuropsychopharmacology and Biological Psychiatry. 2012a ; 37: 132-135
42. Magalhaes PV, Kapczinski F, Nierenberg AA, et al. Illness burden and medical comorbidity in the Systematic Treatment Enhancement Program for Bipolar Disorder. Acta Psychiatrica Scandinavica. 2012b ; 125: 303-308
43. Magalhaes PVS, Fries GR, Kapczinski F. Peripheral markers and the pathophysiology of bipolar disorder. Revista De Psiquiatria Clinica. 2012c ; 39: 60-67
44. Montgomery SA, Asberg M. New depression scale designed to be sensitive to change. British Journal of Psychiatry. 1979 ; 134: 382-389 (Pubitemid 9136500)
45. Moylan S, Maes M, Wray NR, et al. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Molecular Psychiatry. 2012 ;:
46. Nordentoft M, Øhlenschlaeger J, Thorup A, et al. Deinstitutionalization revisited: a 5-year follow-up of a randomized clinical trial of hospital-based rehabilitation versus specialized assertive intervention (OPUS) versus standard treatment for patients with first-episode schizophrenia spectrum disorders. Psychological Medicine. 2010 ; 40: 1619-1626
47. Otto MW, Simon NM, Wisniewski SR, et al. Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. British Journal of Psychiatry. 2006 ; 189: 20-25 (Pubitemid 44023325)
48. Perlis RH, Ostacher MJ, Patel JK, et al. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). American Journal of Psychiatry. 2006 ; 163: 217-224 (Pubitemid 44480840)
49. Perlis RH, Dennehy EB, Miklowitz DJ, et al. Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study. Bipolar Disorders. 2009 ; 11: 391-400
50. Perlis RH, Ostacher MJ, Miklowitz DJ, et al. Clinical features associated with poor pharmacologic adherence in bipolar disorder: Results from the STEP-BD study. Journal of Clinical Psychiatry. 2010 ; 71: 296-303
51. Post RM. Mechanisms of illness progression in the recurrent affective disorders. Neurotoxicity Research. 2010 ; 18: 256-271
52. Post RM, Altshuler LL, Frye MA, et al. Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder. Journal of Clinical Psychiatry. 2010 ; 71: 1176-1186
53. Raballo A, Laroi F. Clinical staging: a new scenario for the treatment of psychosis. Lancet. 2009 ; 374: 365-367
54. Reinares M, Colom F, Rosa AR, et al. The impact of staging bipolar disorder on treatment outcome of family psychoeducation. Journal of Affective Disorders. 2010 ; 123: 81-86
55. Sachs GS, Guille C, McMurrich SL. A clinical monitoring form for mood disorders. Bipolar Disorders. 2002 ; 4: 323-327
56. Sachs GS, Thase ME, Otto MW, et al. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biological Psychiatry. 2003 ; 53: 1028-1042 (Pubitemid 36645233)
57. Sachs GS, Nierenberg AA, Calabrese JR, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. New England Journal of Medicine. 2007 ; 356: 1711-1722 (Pubitemid 46658703)
58. Scott J, Paykel E, Morriss R, et al. Cognitive-behavioural therapy for severe and recurrent bipolar disorders - Randomised controlled trial. British Journal of Psychiatry. 2006 ; 188: 313-320
59. Sheehan DV, Janavs J, Baker R, et al. MINI - Mini International Neuropsychiatric Interview - English Version 5.0.0 - DSM-IV. Journal of Clinical Psychiatry. 1998 ; 59: 34-57
60. Solomon DA, Leon AC, Coryell WH, et al. Longitudinal course of bipolar I disorder: duration of mood episodes. Archives of General Psychiatry. 2010 ; 67: 339-347
61. Tedlow J, Fava M, Uebelacker L, et al. Outcome definitions and predictors in depression. Psychotherapy and Psychosomatics. 1998 ; 67: 266-270 (Pubitemid 28386472)
62. Vieta E, Reinares M, Rosa AR. Staging bipolar disorder. Neurotoxicity Research. 2011 ; 19: 279-285
63. Wagenmakers EJ, Farrell S. AIC model selection using Akaike weights. Psychonomic Bulletin and Review. 2004 ; 11: 192-196 (Pubitemid 38652053)
64. Willett JB, Singer JD, Martin NC. The design and analysis of longitudinal studies of development and psychopathology in context: Statistical models and methodological recommendations. Development and Psychopathology. 1998 ; 10: 395-426 (Pubitemid 128433129)
65. Young RC, Biggs JT, Ziegler VE, et al. Rating-scale for mania - reliability, validity and sensitivity. British Journal of Psychiatry. 1978 ; 133: 429-435 (Pubitemid 9006756)